WESTPORT, CT / ACCESSWIRE / October 19, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), CYduct Diagnostics Inc., a leading medical device company committed to revolutionizing women's healthcare, with a primary focus on breast health and wellness, is highlighting the critical significance of Breast Cancer Awareness Month. At CYduct Diagnostics Inc., we are dedicated to pioneering new testing methods that prioritize clinical integrity, patient privacy, and convenience in the quest for enhanced breast healthcare.

Breast Cancer Awareness Month is not only a time of remembrance but also an opportunity to emphasize the urgency of early detection and the vital role it plays in combating breast cancer. With a deep-seated commitment to women's health, CYduct Diagnostics Inc. acknowledges the critical importance of this annual observance.

CEO Dom Gatto shared his thoughts, stating, "Breast Cancer Awareness Month serves as a powerful reminder that breast cancer continues to impact the lives of countless women and their families. We must never underestimate the significance of early detection. It can make all the difference in saving lives. At CYduct Diagnostics Inc., we are unwavering in our dedication to the cause of breast cancer awareness and advancing innovative solutions. Through ongoing research and development, we aim to contribute to a world where breast cancer is detected early and treated effectively."

CYduct Diagnostics Inc. is committed to forging new pathways in breast health and wellness. Our innovative testing methods are designed to empower women and their healthcare providers to detect breast cancer in its earliest stages when treatment is most effective.

As we mark Breast Cancer Awareness Month, CYduct Diagnostics Inc. urges everyone to take action, spread awareness, and support early detection initiatives. Together, we can make a profound impact on breast health, fostering a world where breast cancer is no longer a devastating force.

We encourage shareholders to visit our official corporate social media accounts as noted below for updates. Information on such platforms is not incorporated into this press release.

https://twitter.com/CYductDx
https://www.linkedin.com/company/cyductdx/
https://www.facebook.com/CYductDiagnostics

About CYduct Diagnostics, Inc.:

CYduct Diagnostics Inc. is a medical device company pursuing innovations within the women's healthcare market, primarily breast healthcare and wellness. CYduct is focused on breast health and wellness through new testing methods that prioritize clinical integrity and patient privacy and convenience. The Company's history is rooted in providing quality medical products to healthcare markets across the United States. For more than 30 years, from medical schools to hospitals, physicians have relied on the Company to develop medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.

Additional information on its line of products will be available on the Company's website at: www.CYductDX.com.

FORWARD-LOOKING STATEMENTS; ADDITIONAL INFORMATION

This press release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as "could," "may," "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "proposed," "planned," "potential" and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about CYduct's beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although CYduct believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. CYduct cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company's securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company's Annual Report filing and other filings with the OTC Markets Group (available at www.otcmarkets.com). The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.

CONTACT:

CYduct Diagnostics, Inc.
Investor Relations +1-888-545-9112